Select a State

Global health R&D delivers for Illinois

US government investment in global health R&D has delivered

$60.9 million
to Illinois research institutions
850+ new jobs
for Illinois

Neglected diseases in Illinois

Chikungunya cases
66
Dengue cases
149
HIV diagnoses
14,714
Malaria cases
445
Tuberculosis cases
3,292
West Nile cases
749
Zika cases
110

Illinois's top USG-funded global health R&D institutions

Northwestern University
$24.0 million
University of Illinois at Chicago
$15.3 million
University of Illinois at Urbana-Champaign
$7.4 million
University of Chicago
$4.8 million
Loyola University of Chicago
$4.2 million
Rosalind Franklin University of Medicine and Science
$2.6 million
Rush University Medical Center
$2.5 million

Illinois industry in global health R&D

AbbVie
Location(s):
North Chicago, Mettawa
Astellas
Location(s):
Northbrook
Charles River Laboratories
Location(s):
Benson, Chicago, Roanoke, Secor, Skokie, Toluca, Washburn
Integrated DNA Technologies
Location(s):
Skokie
Lavax
Location(s):
Palatine
Luminex
Location(s):
Northbrook
Takeda Pharmaceuticals USA
Location(s):
Deerfield

Illinois's top areas of global health R&D by USG funding

16.6%
HIV/AIDS
10.8%
Malaria
29.8%
Tuberculosis
15.3%
Diarrheal diseases
8.6%
Salmonella infections
10.9%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
8.2%
Other
Ebola/viral hemorrhagic fevers
Hepatitis C
Non-allocable

Global health R&D at work in Illinois

Researchers at the University of Illinois College of Medicine at Rockford are conducting clinical trials of a vaccine candidate against lymphatic filariasis (LF), one of the world’s most profoundly disfiguring diseases. Commonly known as elephantiasis, LF is transmitted by mosquitos carrying parasitic worms. Currently, at least 36 million people worldwide are living with the severe pain, disability, and stigma of the disease; and 856 million people are at risk

Footnotes